ARTICLE | Clinical News
ImmuCell preliminary Phase I/II results
March 28, 2000 8:00 AM UTC
ICCC reported that 10 of 12 evaluable patients receiving its DiffGAM bovine anti-Clostridium difficile immunoglobulins met the clinical end point of diarrhea reduction. ...